IBIO Trademark
IBIO is a USPTO trademark filed by iBio, Inc. Status: Registered.
Trademark Facts
| Mark | IBIO |
|---|---|
| Serial Number | 98091758 |
| Registration Number | 7511691 |
| Status | Registered |
| Filing Date | 2023-07-19 |
| Registration Date | 2024-09-24 |
| Mark Type | Combined |
| Nice Classes | 042 (Software & IT) |
| Owner | iBio, Inc |
| Attorney of Record | Daniel Chalker |
| Prosecution Events | 20 |
| Latest Event | R.PR on 2024-09-24 |
Goods & Services
Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Research on the subject of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Technical research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made with peptides, proteins, antibodies, and chimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticals, biotechnology, and medicine; Computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligence, medical biotechnology, and pharmaceuticals